Document is current
Any future updates will be listed below
-
Authors
Olbrich, Anne
Niemeyer, Johannes
Seiffert, Hendrik
Ebel, Sebastian
Gros, Olga
Lordick, Florian
Forstmeyer, Dirk
Seehofer, Daniel
Rademacher, Sebastian
Denecke, Timm
Matz-Soja, Madlen
Berg, Thomas
van Bömmel, Florian https://orcid.org/0000-0003-2679-0672
-
Funding
Funding for this research was provided by:
Universität Leipzig
- License Information
-
More Information
Article History
Received: 19 July 2023
Accepted: 9 November 2023
First Online: 6 February 2024
Declarations
:
: The authors have declared that no conflict of interest exist. FL declares honoraria from honoraria for lectures and/or as an advisor from Amgen, Astellas, Astra Zeneca, Bayer, Biontech, BMS, Daiichi Sankyo, Eli Lilly, Elsevier, Falk Foundation, Incyte, Merck, MSD, Novartis, Roche, Servier, Springer-Nature, StreamedUp! His institution has received research support from Astra Zeneca, BMS and Gilead. TD declares honoraria for lectures and/or as advisor from Bayer, Astra Zeneca, IPSEN, Novartis, Merck, Lilly, Roche, Siemens, Canon, Parexel, Perceptive, Takeda, MSD, and b.e. imaging. FvB received grants/research support from BMS, Gilead, Humedics, Roche, and Janssen; received honoraria or consulting fees from AbbVie, Bayer, Gilead, Eisai, Ipsen, Janssen, MSD/Merck, Novartis, and Roche; and participated in a company-sponsored speakers bureau from AbbVie, Bayer, Gilead, Eisai, Ipsen, Janssen, MedUpdate, MSD/Merck, and Novartis. TB received grants/research support from Abbvie, BMS, Gilead, MSD/Merck, Humedics, Intercept, Merz, Norgine, Novartis, Orphalan and Sequana Medical; received honoraria or consulting fees from Abbvie, Alexion, Albireo, Bayer, Gilead, GSK, Eisai, Enyo Pharma, HepaRegeniX GmbH, Humedics, Intercept, Ipsen, Janssen, MSD/Merck, Novartis, Orphalan, Roche, Sequana Medical, SIRTEX, SOBI, and Shionogi; and participated in a company-sponsored speakers bureau from Abbvie, Advance Pharma, Alexion, Albireo, Bayer, Gilead, Eisai, Falk Foundation, Intercept, Ipsen, Janssen, MedUpdate GmbH, MSD/Merck, Novartis, Orphalan, Sequana Medica, SIRTEX, and SOBI.
: The study design and all experimental procedures were approved by the Ethics Committee of the University of Leipzig (ethics committee project numbers 006–09 and 112/18-ek) and conducted in accordance with the Declaration of Helsinki.
: Written informed consent was obtained from all individual participants included in the study.
